| dc.contributor.author | Gadbaw, Brian | |
| dc.contributor.author | Karakas, Zeynep | |
| dc.contributor.author | Hollaender, Norbert | |
| dc.contributor.author | Mahuzier, Bruyere | |
| dc.contributor.author | Taher, Ali T. | |
| dc.contributor.author | AYDINOK, YEŞİM | |
| dc.contributor.author | Cassinerio, Elena | |
| dc.contributor.author | Siritanaratkul, Noppadol | |
| dc.contributor.author | Kattamis, Antonis | |
| dc.contributor.author | Maggio, Aurelio | |
| dc.date.accessioned | 2021-03-05T13:18:36Z | |
| dc.date.available | 2021-03-05T13:18:36Z | |
| dc.identifier.citation | AYDINOK Y., Karakas Z., Cassinerio E., Siritanaratkul N., Kattamis A., Maggio A., Hollaender N., Mahuzier B., Gadbaw B., Taher A. T. , "Efficacy and Safety of Ruxolitinib in Regularly Transfused Patients with Thalassemia: Results from Single-Arm, Multicenter, Phase 2a Truth Study", 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 3 - 06 Aralık 2016, cilt.128 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_b1999079-b3dc-430b-9a86-3933b0ca78da | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/118314 | |
| dc.identifier.uri | https://doi.org/10.1182/blood.v128.22.852.852 | |
| dc.language.iso | eng | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Hematoloji | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | HEMATOLOJİ | |
| dc.title | Efficacy and Safety of Ruxolitinib in Regularly Transfused Patients with Thalassemia: Results from Single-Arm, Multicenter, Phase 2a Truth Study | |
| dc.type | Bildiri | |
| dc.contributor.department | Ege Üniversitesi , Tıp Fakültesi , Çocuk Sağlığı Ve Hastalıkları Ana Bilim Dalı | |
| dc.identifier.volume | 128 | |
| dc.contributor.firstauthorID | 150430 | |
